calendar
18,993 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma
18,993 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma
Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION
Sponsor: SUN PHARM INDUSTRIES. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: LUPIN LTD. Form: TABLET. Route: ORAL
Sponsor: EUGIA PHARMA. Form: TABLET. Route: ORAL
Sponsor: HERITAGE. Form: TABLET. Route: ORAL
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: BAYER HLTHCARE. Form: CAPSULE. Route: ORAL
Sponsor: SYNDAX. Form: TABLET. Route: ORAL
Sponsor: SECURA. Form: CAPSULE. Route: ORAL
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL
Sponsor: HIKMA PHARMS. Form: TABLET. Route: ORAL
Sponsor: SANDOZ. Form: TABLET. Route: ORAL
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: B BRAUN MEDICAL. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL
Sponsor: AMPHASTAR PHARMS INC. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: MSN. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: ROBERTS OXYGEN CO INC. Form: GAS. Route: INHALATION
Sponsor: PLIVA. Form: TABLET. Route: ORAL
Sponsor: BRISTOL-MYERS SQUIBB. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: BRISTOL-MYERS SQUIBB. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: CARNEGIE. Form: CAPSULE. Route: ORAL
Sponsor: AJENAT PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION
Sponsor: SANDOZ. Form: EMULSION. Route: OPHTHALMIC
Sponsor: TWI PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: NAVINTA LLC. Form: TABLET. Route: ORAL
Sponsor: BAYER HLTHCARE. Form: SPRAY, METERED. Route: NASAL
Sponsor: BIOVITRUM AB. Form: VIAL. Route: SUBCUTANEOUS
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: MSN. Form: TABLET. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: INJECTABLE. Route: INJECTION
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: INJECTABLE. Route: INJECTION
Sponsor: ELI LILLY AND CO. Form: INJECTABLE. Route: INJECTION
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: AZURITY. Form: TABLET. Route: ORAL
Sponsor: CHANGZHOU PHARM. Form: TABLET. Route: ORAL
Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: TARO. Form: TABLET. Route: ORAL
Sponsor: QILU PHARM HAINAN. Form: INJECTABLE. Route: INJECTION
Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTABLE. Route: INJECTION
Sponsor: VIIV HLTHCARE. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: VIIV HLTHCARE. Form: TABLET, FOR SUSPENSION. Route: ORAL